New nivolumab combination therapies for AML

There has historically been less novel agents being tested and moving into the clinic for AML. Now, there has been a wave of promising trials. Speaking from the American Society of Hematology (ASH) 20... Author: VJHemOnc Added: 12/13/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts